We spoke with Teresa Quattrin (University at Buffalo, Oishei Children’s Hospital) following her presentation of the T1GER study, which investigated the effect of treatment with golimumab in children, adolescents, and young adults with newly diagnosed type 1 diabetes.
Disclosures: Tersea Quattrin discloses the following: Consultant to Janssen Research & Development
Clinical Trial, Principal Investigator at the Buffalo site: Janssen, Provention Bio, Inc., OPKO Biologics Ltd., and Ascendis.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of the European Association for the Study of Diabetes (EASD) 2020.
Share this Video
Related Videos In Diabetes
Sanjay Kalra: Research Highlights from 2021
We were delighted to speak with our editorial board member Dr Sanjay Kalra (Bharti Hospital, Karnal, India) around last year’s research highlights in the field of diabetes and obesity. Questions In the field of diabetes and obesity, what have been the most exciting research highlights of 2021? (0:32) What is your advice for health care […]
Gian Paolo Fadini, EASD 2021: Real-world Data from the RESTORE-2 Study
touchENDOCRINOLOGY caught up with Prof Gian Paolo Fadini (University Hospital of Padova, Italy) virtually during the EASD Annual Meeting 2021 conference to discuss the real-world data from the RESTORE-2 study. Questions 1. What have randomized controlled trials taught us about the efficacy and safety of second-generation basal insulins? (00:18-01:31) 2. What were the aims, design […]
Anna-Maria Lampousi, EASD 2021: Dietary Factors and Risk of Islet Autoimmunity and Type 1 Diabetes
touchENDOCRINOLOGY caught up with Anna-Maria Lampousi (Karolinska Institutet, Stockholm, Sweden) virtually during the EASD Annual Meeting 2021 conference to discuss her systematic review and meta-analysis on dietary factors and risk of islet autoimmunity and type 1 diabetes. Questions 1. What is known about the associations between dietary components and type 1 diabetes, and what gaps […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!